The United States will recommend boosters for most Americans 8 months after the vaccination

The Washington-Biden administration has decided that most Americans should get the corona virus booster vaccine eight months after receiving their second shot, and may begin offering a third shot in mid-September.

Authorities plan to announce the decision earlier this week. Their goal is to convince Americans receiving Pfizer-Biotech or modern vaccines that they will need additional protection against the delta’s variability, which is increasing cascades in most parts of the country. The new policy will be subject to the Food and Drug Administration’s permission for additional shots.

Officials said they expect recipients of the Johnson & Johnson vaccine, which was authorized as a single dose, will also need additional doses. But they are awaiting the results of the firm’s two food clinical trials, which are expected later this month.

The first booster is likely to go to nursing home residents, healthcare workers and emergency workers. Behind them will probably be other older people who have been on the line since the vaccine was launched late last year, then by the general population. Officials thought of giving people the same vaccine they actually received.

The decision comes as the Biden administration struggles to regain control of an epidemic that it claimed was overpowered a month ago. President Biden announced the reopening of the nation to normal life for the July 4 holiday, but the Delta’s various wildfires have thwarted it. Covid 19 patients have once again taken over some state hospitals, and federal officials are worried about an increase in the number of children admitted to the hospital as the school year approaches.

For weeks, Biden administration officials have been analyzing the rise in cases of Covid 19, trying to determine whether the Delta variant is able to avoid the vaccine, or whether the vaccine’s potency is diminishing over time. According to some administration experts, both may be true, a disturbing combination that is re-activating an epidemic that the nation had high hopes for.

“There is a concern that the vaccine may start to run out,” Dr. Frances S. Collins, director of the National Institutes of Health, told Fox News Sunday. He said it could order boosters, combined with the intensity of the Delta variant.

Federal health officials are particularly concerned about data from Israel, which says that the Pfizer-biotech vaccine’s protection against serious illness has dropped significantly for the elderly who died in January or February. I got another shot.

In some ways, Israel can be seen as a template for the United States because it has rapidly vaccinated its large population and used almost exclusively Pfizer-Biotech technology, which accounts for a large portion of US stock. Is. Unlike the United States, however, Israel has a national health system that allows it to track patients on a regular basis.

The latest Israeli figures, published on a government website on Monday, show that some experts have described the effectiveness of the Pfizer vaccine as permanently against mild or asymptomatic Covid 19 infections and against severe disease in the elderly. What are the people who were given the initial vaccine? Year.

A slide shows that for those 65 years of age or older who received their second shot in January, the vaccine is now only 55% effective against severe disease. But researchers noted that there was a wide margin of error in the data, and some said that other figures from the Israeli government showed that the decline in efficiency was less severe.

“It shows a significant reduction in the effectiveness against the infection, but it’s still a bit messy in terms of protection against severe disease,” said Dr. Peter J. Hoetz, a vaccine specialist at the Baylor College of Medicine in Houston. New York Times request

Dr. Jesse L. Goodman, a former chief scientist at the Food and Drug Administration who also reviewed the data, said it showed “alarming trends” that could signal the end of the vaccine’s effectiveness. But he said he would like to see more details from Israel and more important figures would indicate whether the United States is moving in that direction.

Federal officials said the booster program would probably follow the same scenario as the initial vaccination program. The first shots were made available to the general public in the United States on December 14, just days after the FDA authorized Pfizer shots for emergency use. People started taking the modern vaccine a week later.

While frontline healthcare workers and nursing home residents were among the first to be vaccinated nationwide, states implemented their plans to determine who was eligible for shots in the early weeks and months of the vaccination campaign.

But about 65 people aged 65 and over qualified for the vaccination by the end of February, as many police officers, teachers, grocery store employees and others at work were at risk of contracting the virus. Was

The regulatory path for additional shots is not entirely clear. Pfizer-Biotech submitted data to the FDA on Monday stating that the safety and effectiveness of the booster shot had been demonstrated. But the data were preliminary, from Phase 1 of the clinical trial. Modern is on a similar path, exploring the safety and efficacy of both a half dose and a full dose as a third shot.

The World Health Organization has called for a ban on booster shots by the end of September, saying available food should be used to help countries lag far behind in vaccination. But Israel is already giving a third shot to at least 50-year-olds. Germany and France have said they plan to offer additional shots to the weaker sections of their population next month. The UK has a plan to do so, but is currently blocking it.

Last weekend, the FDA approved a third dose of Pfizer and modern vaccines for some people with weakened immune systems, and the Centers for Disease Control and Prevention recommended them. Authorities ruled that people, who make up less than 3% of Americans, deserve extra shots because many people fail to respond to a standard diet. The agency has not yet approved the vaccine for children under 12.

Leave a Reply

Your email address will not be published. Required fields are marked *